Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Emcor Group (EME) .Emcor Group currently has an average brokerage recommen ...

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Diversified Energy Company PLC (DEC) .Diversified Energy Company PLC curre ...

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though?Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Sterling Infrastructure (STRL) .Sterling Infrastructure currently ...

苹果公司周四被两家机构下调评级，成为市场对这家iPhone制造商持谨慎态度的最新迹象。今年以来， 苹果表现大幅落后于其他大型科技股。随着评级下调，苹果的"推荐一致性"（即买入、持有和卖出评级 的比例指标）已降至3.9（满分为5分），创2020年初以来最低水平。在彭博追踪的分析师中，仅有55% 的人推荐买入该股，在大型科技股中属极低水平。相比之下，英伟达、微软和亚马逊均超过90%。 来源：滚动播报 ...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.Daiwa Capital analyst Jairam Nathan initiated coverage on Eaton Corporation plc ETN with an Outperform rating and announced a price target of $390. Eaton shares closed at $362.25 on Wednesday. See how other analysts view this stock.Deutsche Bank analyst Ross Seymore initiated coverage on Synaptics Incorporate ...

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?Let's take a look at what these Wall Street heavyweights have to say about DraftKings (DKNG) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.DraftKings currently has an average brok ...

股价表现与分析师调整 - Diamondback Energy股价单日下跌超过5% 而标普500指数同期上涨0.5% [1] - KeyBanc资本市场分析师Tim Rezvan将目标价从180美元下调至176美元 但维持"增持"评级 [2] 业务与财务动态 - 子公司Viper Energy以41亿美元现金收购Sitio Royalties 交易于8月中旬完成 [5] - Viper Energy将第三季度产量指引调整为每日10.4-11万桶油当量 [5] - 公司第二季度收入同比增长近50% 达到36.8亿美元 [6] - 调整后净利润为7.85亿美元 虽同比下降但仍保持盈利 [6] 战略调整与市场因素 - 公司下调天然气价格预期 促使分析师调整目标价 [4] - Viper Energy在收购同时宣布将基础股息提高10% [4]

核心财务表现 - 第二季度调整后每股收益4.52美元 超出市场预期的4.24美元 去年同期为亏损12.83美元[2] - 总营收29.6亿美元 超出市场预期的28.9亿美元 同比增长12%[3] - 美国市场营收18.5亿美元 同比增长14% 国际市场营收11.2亿美元 同比增长8%[4] - 调整后运营收入13.3亿美元 去年同期为调整后运营亏损31.5亿美元[14] 产品线销售表现 - 主力产品Trikafta销售额25.5亿美元 同比增长4.2% 略低于市场预期但超出内部模型预期[5] - 新产品Alyftrek销售额1.568亿美元 较第一季度5390万美元大幅增长 在美国市场呈现稳定增长态势[6] - 基因疗法Casgevy销售额3040万美元 环比增长114.1% 已有75个治疗中心激活 115名患者开始细胞收集 29名患者完成输注[8][9] - 新药Journavx销售额1200万美元 自3月中旬上市至7月中旬已获得超过11万张处方[10] - 其他产品收入2.361亿美元 同比增长20.2%[7] 成本与费用结构 - 调整后研发费用8.781亿美元 同比增长25.9% 主要用于支持四项关键三期临床研究[13] - 调整后销售及行政费用3.594亿美元 同比增长28.2% 主要用于支持Journavx的上市推广[13] - 收购相关研发成本220万美元 去年同期为44.4亿美元[14] 2025年业绩指引 - 维持全年营收指引118.5-120亿美元 中点增长率为8%[15] - 预计研发及行政费用合计49-50亿美元 将处于指引范围高端[16] - 调整后税率指引维持20.5%-21.5%[16] - 收购相关研发费用预计约1亿美元[16] 资本管理与人事变动 - 宣布新增40亿美元股票回购计划 叠加2023年授权的30亿美元计划中剩余5.7亿美元额度[17] - 首席科学官David Altshuler将于2026年8月退休 全球研究高级副总裁Mark Bunnage将于2026年2月接任[17] 行业比较 - 同业公司Agios制药第二季度营收1245万美元 同比增长44.6% 每股亏损1.93美元[22] - Agios制药预计当前季度每股亏损1.94美元 市场预期在过去30天内下调1.1%[23]

A month has gone by since the last earnings report for Encompass Health (EHC) . Shares have added about 8.6% in that time frame, outperforming the S&P 500.But investors have to be wondering, will the recent positive trend continue leading up to its next earnings release, or is Encompass Health due for a pullback? Well, first let's take a quick look at its most recent earnings report in order to get a better handle on the recent catalysts for Encompass Health Corporation before we dive into how investors and ...

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Marathon Digital Holdings, Inc. (MARA) .Marathon Digital currently has an average brokerage rec ...